The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 07, 2023

Filed:

Jun. 06, 2022
Applicant:

Modra Pharmaceuticals B.v., HN Amsterdam, NL;

Inventors:

Jacob Hendrik Beijnen, HN Amsterdam, NL;

Johannes Henricus Schellens, HN Amsterdam, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61P 35/00 (2006.01); A61K 31/426 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 31/426 (2013.01); A61P 35/00 (2018.01);
Abstract

Treatments of cancers involve a wide range of treatment. The current invention relates to chemotherapy of tumors using taxanes, in particular docetaxel. More in particular it relates to a method for the treatment of a cancer in a patient comprising orally administering an effective dose of docetaxel, whereby side effects are controlled by preventing peak plasma levels of docetaxel that induce said side effects, whilst maintaining an effective plasma level of docetaxel to eradicate tumor cells.


Find Patent Forward Citations

Beijnen, Jacob. (2023). Cancer treatment using docetaxel by controlling peak plasma levels (U.S. Patent No. 11571408). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11571408

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…